Edwards Lifesciences price target raised to $80 from $77 at Evercore ISI

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $80 from $77 and keeps an In Line rating on the shares after Edwards delivered what the firm says was “a solid quarter with revenues surpassing expectations.” The company’s FY25 guidance raise signals confidence in continued growth, the analyst tells investors in a post-earnings note.